SCHEMBL8632186

SCHEMBL8632186

CC(C)(C)OC(=O)c1[nH]nc(-c2ccc(S(N)(=O)=O)cc2)c1-c1ccc(Cl)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 7/20 0.51
CA2 P00918 7/20 0.51
CA12 O43570 6/20 0.51
CA9 Q16790 6/20 0.51
CA14 Q9ULX7 2/20 0.51
PTGS2 P35354 6/20 0.44
PTGS1 P23219 4/20 0.44
CA4 P22748 2/20 0.43
CA7 P43166 2/20 0.43
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
TTK P33981 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
CA3 P07451 1/20 0.39
CA6 P23280 1/20 0.39
CA5A P35218 1/20 0.39
CA13 Q8N1Q1 1/20 0.39
CA5B Q9Y2D0 1/20 0.39
CHRNA7 P36544 1/20 0.39
MAOA P21397 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8631092 0.90 PTGS2 (0.46) CA1CA2CA12CA9CA14
SCHEMBL8179843 0.88 CA1 (0.55) CA1CA2CA12CA9CA14
SCHEMBL8174619 0.86 CA1 (0.46) CA1CA2CA12CA9CA14
SCHEMBL8181133 0.85 CDC25B (0.53) CA1CA2CA12CA9PTGS2
SCHEMBL7772912 0.83 CA1 (0.52) CA1CA2CA12CA9CA14
SCHEMBL7773067 0.83 PTGS2 (0.47) CA1CA2CA12CA9CA14
SCHEMBL7779806 0.81 PTGS2 (0.46) CA1CA2CA12CA9CA14
SCHEMBL8177293 0.79 PTGS2 (0.43) CA1CA2CA12CA9PTGS2
SCHEMBL7779394 0.77 CA1 (0.54) CA1CA2CA12CA9PTGS2
SCHEMBL8167385 0.77 PTGS2 (0.48) CA1CA2CA12CA9PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5756530-A NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G. D. SEARLE & CO. (US) 1998-05-26 US disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed